The estimated Net Worth of Jean Deleage is at least $17.2 Millón dollars as of 26 July 2005. Jean Deleage owns over 171,997 units of Rigel Pharmaceuticals stock worth over $150,504 and over the last 21 years Jean sold RIGL stock worth over $17,028,082.
Jean has made over 9 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Jean sold 114,239 units of RIGL stock worth $723,133 on 1 December 2006.
The largest trade Jean's ever made was selling 177,600 units of Rigel Pharmaceuticals stock on 21 October 2004 worth over $4,448,880. On average, Jean trades about 38,900 units every 38 days since 2003. As of 26 July 2005 Jean still owns at least 11,604 units of Rigel Pharmaceuticals stock.
You can see the complete history of Jean Deleage stock trades at the bottom of the page.
Jean's mailing address filed with the SEC is ONE EMBARCADERO CENTER SUITE 450, , SAN FRANCISCO, CA, 94111.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke y Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: